Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Personal Injury

The Yasmin/Yaz lawyers at the Dr. Shezad Malik Law Firm are investigating potential Yasmin/Yaz lawsuits throughout the United States for claims on behalf of patients who took the drug and now suffer from deep vein thrombosis (blood clots in legs), pulmonary embolism, and/or strokes. Yasmin/Yaz have also been associated with heart attacks and death. These Yasmin/Yaz lawsuits allege product liability, negligence and failure to warn claims against Bayer Healthcare Pharmaceutical.

A MDL hearing has been set in the JPML Court in Richmond, Virginia on September 24, 2009.

Continue reading

The Fleet Phospho-soda attorneys at Dr. Shezad Malik Law Firm are investigating potential lawsuits for individuals who have suffered severe kidney damage after a colonoscopy prep where Fleet Phospho-soda was used.

While most patients only became aware of the potential for Fleet Phospho-soda kidney problems when the product was recalled in December 2008, the manufacturer has been aware of the potential side effects for years.

Continue reading

YAZ, also known as Yasmin or by its generic name Ocella is a birth control pill originally developed and manufactured by Berlex Laboratories, (a U.S affiliate of Schering AG).

YAZ, Yasmin, Ocella (drospirenone and ethinyl estradiol) is a combination birth control pill which contain two types of hormones: estrogen and a progestin. It is the only 24/4-day pill with the unique hormone, drospirenone (drsp) and its manufacturer claims that the product provides additional health benefits other then pregnancy prevention.

Continue reading

Fleet Phospho Soda, a laxative product used for varying applications, was the subject of a December 2008 consumer alert from the FDA (the U.S. Food and Drug Administration). The alert warned that the use of phosphate-based laxatives such as Fleet Phospho Soda could result in kidney failure, even among individuals who do not have a medical condition that puts them at risk for kidney failure.

Fleet Phospho Soda is available without a prescription, it is a non-prescription laxative. It is widely used to clean the intestines before a colonoscopy and other medical procedures.

The Phospho Soda works by drawing fluid from the rest of the body into the colon; if an individual does not consume enough water or other fluids during Phospho Soda use, he or she may become dehydrated. The individual’s level of phosphate salts in the kidneys may also become too high — a development that can result in a type of kidney damage called acute phosphate nephropathy (APN).

Continue reading

Yaz is a relatively new oral birth control medication. But an unfortunate number of patients have found, Yaz also causes serious, and life-threatening side effects including pulmonary embolism (blood clots to the lung), heart attack and stroke.

Bayer HealthCare Pharmaceuticals Inc. – the drug’s manufacturer – before being regulated by the U.S. Food and Drug Administration in a recent mandate, marketed Yaz which minimized these very serious side effects, and misleading millions of women about the safety of this medication.

If you’re taking the prescription medication Yaz or Yasmin, also manufactured by Bayer, and have had any of the side effects associated with these compounds, you may be entitled to compensation.

Continue reading

The state Court of Appeals has overturned a $53 million damage award to the family of an Albuquerque woman who died in a nursing home.

The court ordered a new trial. The daughter of 78-year Barbara Barber filed a lawsuit alleging her mother died in December 2004 of gastrointestinal bleeding that went untreated by the nursing home staff.

In tossing out the jury verdict, the appeals court said a district judge was wrong in a pretrial finding that ManorCare Inc., a Toledo, Ohio-based company, was the employer of the nursing home’s staff. The court said there was conflicting evidence on that issue. ManorCare contended that a subsidiary company owned and operated the Albuquerque nursing home, which was sold in 2005.

Continue reading

Reports are now surfacing that women using Yasmin and Yaz birth control pills are developing gallbladder problems. Some women have had to undergo gall bladder removal surgery due to gallstones. Gall bladder disease includes inflammation, infection, stones, or obstruction of the gallbladder. There are two main types of gallbladder disease: cholecystitis (inflammation of the gallbladder) and cholelithiasis (gallstones).

We are currently evaluating and representing women who have suffered from gallbladder complications while on Yasmin birth control including gallbladder removal.

Continue reading

Recent reports have noted possible dangers of Yasmin/Yaz in persons with some preexisting conditions. Federal lawsuits filed recently allege that since Yasmin and Yaz have been available, there have been over 50 related deaths and hundreds of serious health concerns due to complications with the medicine.

Yasmin and Yaz lawsuits filed allege that Bayer failed to adequately warn about the increased risk of serious heart and health problems associated with their birth control when compared to other available pills. They not only minimized the blood clot risk with Yaz and Yasmin, but also heavily marketing the drugs through deceptive advertisements designed to encourage doctors and patients to use their birth control pill over other available forms that may not present as great of a risk.

Continue reading

Avandia, an oral medication produced by GlaxoSmithKline, improves control of blood glucose levels in individuals with type-2 diabetes. Despite its ability to make insulin receptors more sensitive, Avandia does have some serious associated risks, as it can increase the chances that patients’ develop:

* stroke
* congestive heart failure
* heart attack
* liver toxicity
* severe allergic reactions

Continue reading

A panel of federal judges will hear arguments later in September to determine whether all federal lawsuits against Bayer Pharmaceuticals Corporation over serious and potentially life threatening side effects of Yaz and Yasmin birth control should be centralized and consolidated in one district for coordinated handling as part of an MDL, or Multidistrict Litigation.

According to a notice recently issued by the U.S. Judicial Panel on Multidistrict Litigation, a hearing will be held on September 24 to consider whether the cases filed in various federal districts throughout the United States involve sufficiently common questions of fact and whether consolidation is appropriate.

Continue reading

Contact Information